NetworkNewsBreaks – Neuralstem, Inc. (CUR) Shares Higher; finalizes $20M Strategic Investment from Tianjin Pharmaceutical Group
Neuralstem (NASDAQ: CUR) is trading 9% higher after reporting the close of a $20 million investment from Tianjin Pharmaceutical Group International Holdings Co., LTD in an arrangement Neuralstem says will “complement and support” R&D initiatives. Tianjin received 28.5 million shares of common stock and 1 million shares of Series A convertible preferred stock that cannot be converted if the shares received and the common shares would result in Tianjin having voting power in excess of 19.99% of the company. Tianjin is also authorized to appoint one member to the company’s board of directors. To view the full press release, visit:…







